These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 20505489)

  • 1. Minimizing joint damage: the role of nurses in promoting adherence to hemophilia treatment.
    Khair K
    Orthop Nurs; 2010; 29(3):193-200; quiz 201-2. PubMed ID: 20505489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Joint outcomes in patients with haemophilia: the importance of adherence to preventive regimens.
    Berntorp E
    Haemophilia; 2009 Nov; 15(6):1219-27. PubMed ID: 19659939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathophysiology, diagnosis and prevention of arthropathy in patients with haemophilia.
    Dunn AL
    Haemophilia; 2011 Jul; 17(4):571-8. PubMed ID: 21342365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Status of joint and intracranial bleeding of moderate and severe hemophilia in children under on-demand therapy].
    He WW; Wu RH
    Zhonghua Er Ke Za Zhi; 2012 Aug; 50(8):636-8. PubMed ID: 23158747
    [No Abstract]   [Full Text] [Related]  

  • 5. Orthotic management of the knee in patients with hemophilia.
    Heim M; Martinowitz U; Horoszowski H
    Clin Orthop Relat Res; 1997 Oct; (343):54-7. PubMed ID: 9345206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prophylactic treatment with clotting factor to prevent joint damage in patients with severe haemophilia: costs versus benefits].
    Roosendaal G; Lafeber FP
    Ned Tijdschr Geneeskd; 2007 Nov; 151(47):2606-8. PubMed ID: 18161260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adherence to prophylactic infusions of factor VIII or factor IX for haemophilia.
    Thornburg CD; Pipe SW
    Haemophilia; 2006 Mar; 12(2):198-9. PubMed ID: 16476098
    [No Abstract]   [Full Text] [Related]  

  • 8. Prophylactic treatment with activated prothrombin complex concentrate (FEIBA) reduces the frequency of bleeding episodes in paediatric patients with haemophilia A and inhibitors.
    Leissinger CA; Becton DL; Ewing NP; Valentino LA
    Haemophilia; 2007 May; 13(3):249-55. PubMed ID: 17498073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimizing factor prophylaxis for the haemophilia population: where do we stand?
    Blanchette VS; Manco-Johnson M; Santagostino E; Ljung R
    Haemophilia; 2004 Oct; 10 Suppl 4():97-104. PubMed ID: 15479380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meeting unmet needs in inhibitor patients.
    Blanchette VS; Manco-Johnson MJ
    Haemophilia; 2010 May; 16 Suppl 3():46-51. PubMed ID: 20586802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The phenotypic heterogeneity of severe hemophilia.
    Jayandharan GR; Srivastava A
    Semin Thromb Hemost; 2008 Feb; 34(1):128-41. PubMed ID: 18393149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arthropathy in children with severe hemophilia A.
    Soreff J; Blombäck M
    Acta Paediatr Scand; 1980 Sep; 69(5):667-73. PubMed ID: 6785993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Supporting adherence and improving quality of life in haemophilia care.
    Khair K
    Br J Nurs; 2013 Jun 27-Jul 10; 22(12):692. PubMed ID: 24151707
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevention and treatment of musculoskeletal disease in the haemophilia population: role of prophylaxis and synovectomy.
    Van den Berg HM; Dunn A; Fischer K; Blanchette VS
    Haemophilia; 2006 Jul; 12 Suppl 3():159-68. PubMed ID: 16684012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current issues in prophylactic therapy for persons with hemophilia.
    Dunn AL; Abshire TC
    Acta Haematol; 2006; 115(3-4):162-71. PubMed ID: 16549891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experience with prophylaxis in Germany.
    Schramm W
    Semin Hematol; 1993 Jul; 30(3 Suppl 2):12-5. PubMed ID: 8367737
    [No Abstract]   [Full Text] [Related]  

  • 17. Assessing the benefits of FEIBA prophylaxis in haemophilia patients with inhibitors.
    Valentino LA
    Haemophilia; 2010 Mar; 16(2):263-71. PubMed ID: 20028421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experience with prophylaxis in Sweden.
    Nilsson IM
    Semin Hematol; 1993 Jul; 30(3 Suppl 2):16-9. PubMed ID: 8367738
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of hemophilia.
    Rodeghiero F
    Ric Clin Lab; 1985; 15(4):289-303. PubMed ID: 3914697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central venous access devices in patients with hemophilia.
    Valentino LA; Kapoor M
    Expert Rev Med Devices; 2005 Nov; 2(6):699-711. PubMed ID: 16293097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.